Covid-19 and Rehabilitation Outcomes: A Case-Control Study

被引:1
|
作者
Petzold, Stefanie [1 ]
Carney, Roisin [2 ]
Kool, JanPieter [3 ]
Bachmann, Stefan [4 ,5 ]
机构
[1] Kliniken Valens Rehazentrum Walenstadtberg, Klin Muskuloskelettale & Internist Rehabiltat, Walenstadt, Switzerland
[2] Kliniken Valens Rehazentrum Walenstadtberg, Physiotherapien, Walenstadt, Switzerland
[3] Forschungsabteilung, Kliniken Valens Rehazentrum Valens, Valens, Switzerland
[4] Kliniken Valens Rehazentrum Valens, Klin Muskuloskelettale & Internist Rehabil, Taminapl 1, CH-7317 Valens, Switzerland
[5] Univ Bern, Univ Hosp Bern, Dept Geriatr, Inselspital,Fac Med, Bern, Switzerland
关键词
Sars-CoV-2; Covid-19; rehabilitation; therapy; outcomes; COHORT;
D O I
10.1055/a-1729-7706
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective Does the rehab process of acutely ill Covid-19 patients differ from recovered Covid-19 patients and other rehab patients? Comparison of the reha-course between acutely ill Covid-19 patients, recovered patients and rehab patients without Covid-19. Design: case-control study. Material and Methods Patients assigned to rehab in the period from 01.04 to 30.06.2020 with active Covid-19 disease (IG), recovered Covid-19 patients (PCG) and simultaneously rehabilitated persons matched by age, gender and comorbidity (Ko) were included. The primary endpoint was ADL- independence (FIM), secondary endpoints were quality of life (EQ5D-VAS), physical and mental health (PROMIS10) and mobility (TUG and 6MWT). Results 101 patients were included: IG=15; PCG=22; Ko=64. At entry, ADL-independence and quality of life were significantly highest in the IG (FIM IG 95.3 vs. PCG 78.3, vs. Ko 79.6; ANOVA p=0.029; EQ5D-VAS IG 56.1 vs. PCG 36.6 vs. Ko 51.0; ANOVA p=0.010). There were no differences in PROMIS10 and mobility. All three groups improved significantly from entry to discharge. The IG performed best in the FIM (IG 109.7 vs. PCG 97.2 vs. Ko 93.6; ANOVA p=0.039). The control group achieved the worst results with regard to mobility at discharge (TUG Ko 19.3 sec vs. 9.6 sec IG and 8.3 sec PCG). In the 6MWT, the PCG showed the best result (471 m vs. IG 416 m and Ko 389 m; difference n.s.). Conclusion All three patient groups benefited well from the rehab program. In addition, rehab measures bring a benefit also for isolated Covid-19 patients. In particular, recovered Covid-19 patients benefit greatly from the rehab program.
引用
收藏
页码:17 / 27
页数:11
相关论文
共 50 条
  • [1] THE IMPACT OF GINGIVITIS AND PERIODONTITIS ON COVID-19 OUTCOMES: A CASE-CONTROL STUDY
    Morrow, C.
    McKenna, R. M.
    Gebauer, E.
    Palmer, L.
    VALUE IN HEALTH, 2022, 25 (07) : S442 - S442
  • [2] Outcomes of Acute Gastrointestinal Bleeding in Patients With COVID-19: A Case-Control Study
    Iqbal, Umair
    Patel, Pooja D.
    Pluskota, Christopher A.
    Berger, Andrea L.
    Khara, Harshit S.
    Confer, Bradley D.
    GASTROENTEROLOGY RESEARCH, 2022, 15 (01) : 13 - 18
  • [3] The effectiveness of postacute intensive rehabilitation on severe COVID-19 patients: A case-control study
    Aliberti, Marlon J. R.
    Levites, Marcelo R.
    Berardo, Frederico A. N.
    HEALTH SCIENCE REPORTS, 2023, 6 (08)
  • [4] Mucormycosis in COVID-19 Patients: A Case-Control Study
    Pandit, Awadh Kishor
    Tangri, Poorvi
    Misra, Shubham
    Srivastava, Madakasira Vasantha Padma
    Bhatnagar, Sushma
    Thakar, Alok
    Sikka, Kapil
    Panda, Smriti
    Vishnu, Venugopalan Y.
    Singh, Rajesh Kumar
    Das, Animesh
    Radhakrishnan, Divya M.
    Srivastava, Achal Kumar
    Subramaniam, Rajeshwari
    Trikha, Anjan
    Agarwal, Ayush
    Rajan, Roopa
    Upadhyay, Vibhor
    Parikipandla, Sathish
    Singh, Anup
    Kairo, Arvind
    MICROORGANISMS, 2022, 10 (06)
  • [5] Maternal, Fetal and Neonatal Outcomes in Pregnant Women with COVID-19: A Case-Control Study
    Sattari, Mahtab
    Samari, Banafshe
    Beheshti, Rezvanehsadat
    Farhadian, Maryam
    Tiznobaik, Azita
    Sepahvand, Saba
    CURRENT WOMENS HEALTH REVIEWS, 2024, 20 (01)
  • [6] Obstetric and Perinatal Outcomes of Maternal COVID-19 Disease. Case-Control Study
    Santos, Cecilia
    Magallanes, Danilo
    Rubinos, Melina
    Danza, Alvaro
    REVISTA MEDICA DEL URUGUAY, 2023, 39 (03):
  • [7] COVID-19 Outcomes Among Solid Organ Transplant Recipients: A Case-control Study
    Sharma, Pratima
    Chen, Vincent
    Fung, Christopher M.
    Troost, Jonathan P.
    Patel, Vaiibhav N.
    Combs, Michael
    Norman, Silas
    Garg, Puneet
    Colvin, Monica
    Aaronson, Keith
    Sonnenday, Christopher J.
    Golob, Jonathan L.
    Somers, Emily C.
    Doshi, Mona M.
    TRANSPLANTATION, 2021, 105 (01) : 128 - 137
  • [8] Pneumomediastinum in COVID-19: Risk factors and outcomes from a multicentre case-control study
    Negri, Stefano
    Mazzuca, Emilia
    Lococo, Filippo
    Mondoni, Michele
    Covino, Marcello
    Kuzmych, Khrystyna
    Agati, Sergio
    Amata, Marta
    Arcoleo, Giuseppe
    Gabbrielli, Luciano
    Pancani, Roberta
    Tedeschi, Ersilia
    Baiamonte, Pierpaolo
    Sassu, Alessandro
    Patrucco, Filippo
    Foci, Valentina
    Marchetti, Giampietro
    Vernuccio, Federica
    Zanardi, Erika
    Gaccione, Anna Talia
    Sorino, Claudio
    RESPIRATORY MEDICINE, 2024, 230
  • [9] COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study
    Peron, Julien
    Dagonneau, Tristan
    Conrad, Anne
    Pineau, Fanny
    Calattini, Sara
    Freyer, Gilles
    Perol, David
    Sajous, Christophe
    Heiblig, Mael
    CANCERS, 2021, 13 (21)
  • [10] COVID-19 cancer patients outcomes in an intensive care setting: A case-control study
    Ranchor, R.
    Pereira, N.
    Medeiros, R.
    Romao, R.
    Ramos, M. J.
    Mendes, A. S.
    Peixoto, I.
    Magalhaes, M.
    Marinho, A.
    Araujo, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1141 - S1141